Melbourne Melanoma Project committed to improving the diagnosis and early detection of melanoma.

Imaging matters when judging ‘risky nevi’

In the past, only clinical factors were used to judge “risky nevi,” but imaging modalities are predictive tools for identifying choroidal nevus risk factors for growth to melanoma, according to Carol L. Shields, MD.

Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey

BACKGROUND: The COVID-19 pandemic imposes major challenges for care of cancer patients.

A Phase IB Study of Belvarafenib Alone and in Combination with Cobimetinib in People with Advanced Melanoma Who Had Immunotherapy

The purpose of this study is to find the highest dose of the investigational drug belvarafenib that can be given safely alone and with cobimetinib in people with advanced NRAS-mutated melanoma that continues to grow despite prior treatment with immunotherapy.

New Insights about Melanocytes Could Lead to More Targeted Melanoma Treatments

Newswise — SALT LAKE CITY – Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) have generated the first “atlas” of human melanocytes located throughout the body.